Business

Nifty 50 and Sensex End Higher as Auto and Pharma Stocks Drive Market Gains

On July 15, 2026, the Indian stock market ended on a positive note. The Nifty 50 climbed 0.45% to reach 25,195, while the Sensex added 0.39% to close at 82,570. Sectoral gains in auto and pharma, led by Hero Motocorp and Sun Pharma, offset losses in the IT sector. Despite Foreign Institutional Investors selling ₹1,614.30 crore, Domestic Institutional Investors supported the market with purchases worth ₹1,787.70 crore, ensuring a steady finish amid mixed global signals.

Rajesh Singh

Rajesh Singh

Jul 15, 2026

57 views

This article was curated with AI assistance and published by the MBN News Desk.

Nifty 50 and Sensex End Higher as Auto and Pharma Stocks Drive Market Gains
AI Generated ImageSource: MBN News Desk

Key Takeaways

  • Nifty 50 rose 0.45% to 25,195 led by auto and pharma
  • Hero Motocorp and Bajaj Auto emerged as top gainers
  • DIIs bought ₹1,787.70 crore to offset FII selling

Mumbai's benchmark indices closed higher on Tuesday, July 15, as gains in the auto and pharmaceutical sectors offset weakness in information technology stocks, offering a measure of stability amid a mixed global backdrop. The Nifty 50 climbed 0.45% to close at 25,195, while the Sensex rose 0.39% to settle at 82,570. The advance was not a sharp rally by any measure, but the fact that both indices managed to hold their ground and finish in positive territory carried some significance given the uncertainty prevailing in markets elsewhere in the world.

The Nifty 50 and Sensex are the two most widely tracked barometers of Indian equity markets, representing 50 and 30 large, actively traded companies respectively across major sectors of the economy. Movements in these indices are closely watched by retail investors, mutual funds, foreign portfolio managers and policymakers alike, as they offer a snapshot of investor sentiment and the broader health of corporate earnings. Tuesday's session reflected a familiar pattern seen during earnings season, when sector-specific results can pull the market in different directions even as headline indices remain relatively steady.

The auto sector clearly stood out as the day's biggest driver of gains. Hero MotoCorp jumped 4.76%, while Bajaj Auto followed with a rise of 2.76%. Such simultaneous movement from two major names in the same sector on the same trading day is not a minor occurrence and points to renewed investor interest in two-wheeler and auto manufacturers. The pharmaceutical sector also performed well, with Sun Pharma gaining 2.67% after it announced a licensing deal with Incyte Corporation for its alopecia treatment, LEQSELVI. Licensing agreements of this kind allow pharmaceutical companies to expand the reach of their drugs through partnerships, and the deal appeared to bolster market confidence in Sun Pharma's broader product pipeline.

In sharp contrast, the information technology sector moved in the opposite direction. HCL Tech dropped 3.30% after reporting a 10% year-on-year decline in its consolidated net profit for the first quarter. A profit decline of that magnitude from one of the country's larger IT services companies is not a minor development, and the market's reaction reflected investor concern over the health of earnings in the sector. IT firms have historically been sensitive to global demand conditions, currency fluctuations and client spending patterns, particularly in markets such as the United States and Europe, making quarterly results from bellwether companies an important signal for the sector as a whole.

Institutional flows played a notable role in supporting the market on Tuesday. Foreign institutional investors sold shares worth ₹1,614.30 crore, continuing a pattern of caution that has been visible in recent sessions, while domestic institutional investors countered with net buying of ₹1,787.70 crore. This offsetting activity between foreign and domestic institutions is common in Indian markets and often determines whether indices can sustain gains or come under pressure on a given day. Elsewhere in the corporate earnings space, Tata Technologies reported a 10% sequential dip in profit, totaling ₹170.28 crore for the first quarter of fiscal year 2026, adding to the mixed tone of the results season.

Infrastructure-linked stocks also saw notable activity during the session. Rail Vikas Nigam Limited, commonly known as RVNL, secured a new contract from the Delhi Metro Rail Corporation, while Power Mech Projects bagged orders worth ₹551.35 crore. Order wins of this nature are typically viewed positively by investors, as they provide visibility into future revenue streams for companies operating in the infrastructure and engineering space, a sector that has drawn sustained government and private investment in recent years.

The global backdrop against which Indian markets traded on Tuesday was notably fragmented. Japan's Nikkei and Hong Kong's Hang Seng posted gains, while the Shanghai Composite slipped 0.40%. European markets stayed mostly flat during mid-session trading, and U.S. futures were signaling a hesitant start for Wall Street later in the day. With no clear directional cue from overseas markets, domestic indices largely had to find their own footing, and the support from domestic institutional buying appeared to be the key factor that helped keep the Nifty and Sensex above key resistance levels.

Derivatives market indicators offered additional insight into trader sentiment heading into the rest of the week. The Nifty put-call ratio, or PCR, stood at 0.5474, a reading that suggests traders are leaning toward caution rather than aggressive positioning. The put-call ratio is a widely used gauge among options traders, reflecting the relative volume of put options to call options and often serving as a proxy for market sentiment. The so-called maximum pain point — the level at which the maximum number of options contracts would expire worthless — was identified at 25,150, strikingly close to where the Nifty actually closed at 25,195. That proximity is likely to draw continued attention from options traders monitoring how the index behaves relative to this level in coming sessions.

Looking ahead, investors are keeping a close watch on the Reserve Bank of India's stance on liquidity conditions alongside the ongoing flow of quarterly corporate results. Earnings season is often a period of complex and sometimes contradictory signals, and this particular stretch has been no exception, with auto and pharma stocks advancing even as IT names retreat. Such sector rotation can make it difficult for investors to read overall market direction with confidence. The key question going forward is whether the momentum in autos and pharmaceuticals has enough strength to sustain the broader market, or whether weak IT earnings combined with lingering global uncertainty could gradually weigh on sentiment in the sessions ahead.

  • Nifty 50 rose 0.45% to 25,195; Sensex gained 0.39% to close at 82,570.
  • Hero MotoCorp surged 4.76% and Bajaj Auto rose 2.76%, while Sun Pharma gained 2.67% on a licensing deal with Incyte Corporation for LEQSELVI.
  • HCL Tech fell 3.30% after a 10% year-on-year drop in quarterly net profit; Tata Technologies reported a 10% sequential profit decline to ₹170.28 crore.
  • FIIs sold ₹1,614.30 crore in shares while DIIs bought a net ₹1,787.70 crore, helping support the market amid mixed global cues.
Source: MBN News Desk
#Nifty 50#Sensex#Hero Motocorp#Sun Pharma#HCL Tech#Stock Market India#Business News#BSE#NSE

Related Articles